共 50 条
- [2] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623
- [4] Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 186 - 186
- [5] A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E245 - E246
- [6] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
- [7] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248
- [9] INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER: UPDATES FROM A PHASE 2 TRIAL [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E1008 - E1008
- [10] A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guerin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder [J]. JOURNAL OF UROLOGY, 2020, 204 (02): : 247 - 253